Join the club for FREE to access the whole archive and other member benefits.

Demis Hassabis

Artificial intelligence researcher, neuroscientist, founder and CEO of DeepMind

Demis Hassabis co-founded DeepMind in 2010 after successful careers in academia and computer game development. A child chess prodigy, he designed and programmed the multi-million selling, award-winning game Theme Park at the age of 17. After graduating from Cambridge University, he founded pioneering videogames firm Elixir Studios and completed a PhD in cognitive neuroscience at UCL. The journal Science listed his research on imagination and memory as one of 2007’s top ten breakthroughs. Demis is a Fellow of the Royal Society, Royal Academy of Engineering and the Royal Society of Arts. In 2017 he featured in the Time 100 list of most influential people, and in 2018 he was awarded a CBE for services to science and technology.

Visit website: https://deepmind.com/about#leadership

 demishassabis

 demishassabis

See also

Google DeepMind

Company developing AI systems for solving problems

Details last updated 30-Jan-2020

Demis Hassabis News

Google's parent company now permits AI use in weapons and surveillance

Google's parent company now permits AI use in weapons and surveillance

BBC - 05-Feb-2025

The company says it’s important for democracies to lead in using AI safely

AI in drug discovery: the future is near

AI in drug discovery: the future is near

The Register - 22-Jan-2025

Machine learning promises faster, cheaper, and more effective treatments

Isomorphic Labs rethinks drug discovery with no labs, just AI

Isomorphic Labs rethinks drug discovery with no labs, just AI

Endpoints News - 12-Dec-2024

This aims to reduce development time but faces challenges in proving real-world success

Nobel prize awarded for AI breakthrough in protein science

Nobel prize awarded for AI breakthrough in protein science

BBC - 08-Oct-2024

AI transforms how we understand and target proteins

Isomorphic Labs partners with Eli Lilly, Novartis to use AI in drug discovery

Isomorphic Labs partners with Eli Lilly, Novartis to use AI in drug discovery

pharmaphorum - 08-Jan-2024

Their AlphaFold engine models proteins could lead to faster and more effective treatments


Display all news

Demis Hassabis is also referenced in the following:

Isomorphic Labs

Discovering new drugs with AI-first approach